Attention-deficit/hyperactivity disorder (ADHD) may affect a significant number of children in a pediatric practice. This article reviews diagnostic criteria, comorbidities, and complications of ADHD as well as pitfalls that confront the treating pediatrician.
Maternal smoking has been linked to later development of attention-deficit/hyperactivity disorder (ADHD) in offspring in many studies, but a recent report shows that heavier smoking increases the risks even more.
Dr. Bass’ recent article in Contemporary Pediatrics, “Personalized medicine, right drug, right patient, right time,” provides a miniature but profound view of what may be the future of pediatric healthcare: focusing on healthcare that is truly individualized through precision science in the areas of diagnosis and treatment, rather than generalized, population-based treatment guidelines.
The premise is to use a patient’s own genetic information to guide decisions for prevention, diagnosis, and treatment of disease and other health conditions.
Diagnosis of attention-deficit/hyperactivity disorder (ADHD) at age 9 years is associated with adverse childhood experiences (ACEs), according to an analysis of data for 1572 children who are part of the Fragile Families and Child Wellbeing Study (FFCWS) birth cohort.
A longitudinal study examined the relationship between prenatal or postnatal high-fat, high-sugar diet and symptoms of attention-deficit/hyperactivity disorder (ADHD) in children who demonstrated either early-onset persistent conduct disorder or minimal conduct problems.
New research examines the effects of behavioral, psychostimulant, and combined treatments on homework issues among children with attention-deficit/hyperactivity disorder (ADHD).
Treating allergic rhinitis (AR) in children with attention-deficit/hyperactivity disorder (ADHD) appears to significantly improve not only AR, but also ADHD symptoms.
Despite concerns about ADHD stimulant therapy as a gateway for future drug abuse, a new study shows that teens treated with stimulants later and for shorter durations, and those treated with non-stimulant medications, have higher rates of later drug abuse than their peers who have used stimulant therapy longer.
The amount of off-label uses of atypical antipsychotic drugs (AAPs) prescribed for children with attention-deficit/hyperactivity disorder (ADHD) raises questions about the appropriateness of AAPs for this indication.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a study published in the Journal of Attention Disorders. The study looked at whether there was a correlation between ADHD and frustration tolerance in children.
Children with ADHD are more likely than their peers to consume less water, exercise less, and spend more time staring at screens-all behaviors that may be negatively affecting their ADHD symptoms, according to a new report.
Two recent studies fail to demonstrate conclusively whether the testing effect can benefit students with ADHD, but both acknowledge the need for more research about teaching strategies for learners with ADHD.
Almost 40% of children and adolescents taking ADHD medications were found to be suffering from bone loss, according to a new report, but researchers are cautioning against changing clinical practices based on these early findings.
What has traditionally been a condition most prevalent among school-aged, white males is increasing among all demographic groups, including females, according to a new report.
Children who are diagnosed with autism spectrum disorder (ASD) during their toddler years may be able lose the designation as they grow up but will continue to have certain ongoing behavioral and special education needs, according to a new study.
Fewer than half of children with attention-deficit/hyperactivity disorder (ADHD) were receiving behavior therapy just before the American Academy of Pediatrics released clinical practice guidelines in 2011, according to the first national study of behavior therapy, medication, and dietary supplements to treat ADHD in children aged 4 to 17 years.
Attention-deficit hyperactivity disorder affects 7.2% of children worldwide, a new meta-analysis estimates.
Many pediatricians fail to provide diagnosis and treatment that meet American Academy of Pediatrics guidelines for children with attention-deficit/hyperactivity disorder (ADHD), a recent study reports.
Children with attention-deficit/hyperactivity disorder are more likely than their peers to develop problems with substance abuse, the American Academy of Pediatrics says in a new clinical report that outlines strategies for reducing the risk.
The Centers for Disease Control and Prevention (CDC) has been monitoring the prevalence of diagnosed and medicated attention-deficit/hyperactivity disorder (ADHD) among children aged 4 to 17 years since 1997, and the evolving data show rates for both measures have been rising steadily and more dramatically in recent years.
Do we all need to wake up to the relationship between attention-deficit/hyperactivity disorder (ADHD) and sleep deficits in our patients?
Acetaminophen use during pregnancy may be linked to attention-deficit/hyperactivity disorder (ADHD) in offspring.
Computer-based cognitive training programs that claim to improve things such as inattentiveness, hyperactivity, and academic and social success in children with attention-deficit/hyperactivity disorder (ADHD) probably don’t live up to those promises.
